A Study of Lapatinib in Combination With Everolimus in Patients With Advanced, Triple Negative Breast Cancer
Status: TERMINATED
Study type: INTERVENTIONAL
Conditions: Breast Neoplasms|Breast Cancer|Cancer of the Breast
Interventions: DRUG: Lapatinib and Everolimus
Sponsor: Emory University